Rezolute, Inc. Common Stock (NV) (RZLT)
PHARMACEUTICAL PREPARATIONS
Rezolute, Inc. Common Stock (NV) (RZLT) is listed on Nasdaq, where it has traded since December 23, 2011.
- Listed On
- Nasdaq
- Listed Since
- December 23, 2011
- Employees
- 58
- Market Cap
- $400M
About Rezolute, Inc. Common Stock (NV)
Rezolute Inc is a late-stage rare disease company focused on developing therapies that treat refractory and debilitating hypoglycemia associated with various forms of hyperinsulinism. Its main clinical asset, Ersodetug, is a potential treatment for refractory hypoglycemia caused by multiple forms of hyperinsulinism. The company has a single reportable segment, which includes all of its activities as a clinical-stage biopharmaceutical company.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 141 institutions reported holding RZLT, with 86.6 million shares worth $450.4 million in aggregate. The largest reported holder was Federated Hermes, with 13.0 million shares worth $67.6 million. Of the 5 largest holders listed below, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Federated Hermes | 12,990,659 | $68M | Unchanged |
| RA Capital Management, | 9,445,039 | $49M | Added 2.89% |
| BlackRock | 7,718,291 | $40M | Added 22.25% |
| Opaleye Management | 6,300,000 | $33M | Unchanged |
| Vanguard | 5,822,793 | $30M | Reduced 18.88% |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is RZLT?
Rezolute, Inc. Common Stock (NV) (RZLT) is listed on Nasdaq, where it has traded since December 23, 2011.
Who are the largest institutional holders of RZLT?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of RZLT were Federated Hermes, RA Capital Management, and BlackRock.
How many institutions own RZLT?
141 institutions reported a position in RZLT for the quarter ended June 30, 2026, worth $450.4 million in total.
Did institutions buy or sell RZLT last quarter?
Of the 5 largest reported holders, 2 added shares, 1 reduced its position and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for RZLT.
Every reported institutional holder, plus insider and congressional trades in RZLT, on SentiSense.